Press release
One of Scotland’s most significant scientific success stories in recent times has been celebrated at a special event hosted by the University of Dundee.
Press release
One of Scotland’s most significant scientific success stories in recent times has been celebrated at a special event hosted by the University of Dundee.
Press release
Two University of Dundee initiatives are to benefit from millions of pounds of UK Government investment.
Press release
Outstanding scientific research at the University of Dundee has been honoured by Scotland’s national academy
Press release
World-leading expertise from the University of Dundee’s Centre for Targeted Protein Degradation (CeTPD) will contribute to a new, global effort to tackle some of the most significant challenges posed by cancer.
Press release
A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases.
Press release
University of Dundee researchers have developed a new molecule that is able to target and bind to a protein class previously considered undruggable by using a masking technique to enter the cell
News
A funding bid led by Dr Rosie Clarke will allow the School to purchase a state-of-the-art spectral flow cytometer to further enhance our research using this technology.
News
Dr Will Farnaby, Principal Investigator in the Centre for Targeted Protein Degradation (CeTPD), has been awarded a Wellcome Trust Early Career Award.
Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
News
Alison McFarlane, a final year PhD student, has been awarded a 2 year Science and Business Fellowship at The Janssen Pharmaceutical Companies Of Johnson & Johnson in Leiden, Netherlands.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Collaborative research between the Universities of Dundee and Cambridge has uncovered how ‘assassin’ immune cells are able keep on killing as they hunt down cancer cells, repeatedly reloading their toxic weapons.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
News
Collaborative research between scientists in the Division of Cell Signalling and Immunology and the University of Leeds has been published in eLife.